Negotiations on the future of the European pharmaceutical industry have stepped up a gear after a crucial vote in the …
Few companies within the UK sector communicate properly via the Internet, according to a new report that found key messages …
Profits at Schering-Plough have been hit by the company's search for a follow-up to its blockbuster allergy drug Claritin.The combined …
Strategic health authorities are too far removed from PCTs to help them innovate as they work on their plans for …
New guidelines from the Medicines and Healthcare Products Regulatory Agency (MHRA) have placed disease awareness campaigns under the spotlight.They spell …
Pharmaceutical companies have spent millions of pounds on websites since the mid-1990s. Although almost no one is prepared to admit …
The last five years have seen a shift in pharmacoeconomics to the centre of corporate concerns. Pharmacoeconomics used to be …
There is a disconnection between what primary care organisation influencers want from a relationship with the pharma industry, and what …
In 1987 the average cost of development for new pharmaceutical products was $231 million, and it took between 10 and …
Medicines Partnership was set up by the Department of Health in January 2002 to encourage people to take their medicines …
When Pharmafocus suggested an article on measuring IT suppliers, this led to much scratching of heads in the Technophobe household.How, …
Being 'client focused' is undoubtedly one of the buzz phrases of recent times, but are recruitment companies really focusing on …
Traditionally, pharma companies have been run as research-based organisations relying on well-integrated internal R&D capabilities to feed their commercial pipelines …
This column takes a healthily sceptical (you might say cynical) view of technological innovations, and tends to the view that …